Differential Expression of Super-Enhancer-Associated Long Non-coding RNAs in Uterine Leiomyomas

Overview

Journal Reprod Sci

Publisher Springer

Specialty Reproductive Medicine

Date 2022 May 31

PMID 35641855

Authors

Tsai-Der Chuang

Derek Quintanilla

Drake Boos

Omid Khorram

Affiliations

Soon will be listed here.

Abstract

Super-enhancer-associated long non-coding RNAs (SE-lncRNAs) are a specific set of lncRNAs transcribed from super-enhancer (SE) genomic regions. Recent studies have revealed that SE-lncRNAs play essential roles in tumorigenesis through the regulation of oncogenes. The objective of this study was to elucidate the expression profile of SE-lncRNAs with concurrent assessment of associated mRNAs in leiomyomas and paired myometrium. Arraystar SE-lncRNAs arrays were used to systematically profile the differentially expressed SE-lncRNAs along with the corresponding SE-regulated protein coding genes in eight leiomyomas and paired myometrium. The analysis indicated 7680 SE-lncRNAs were expressed, of which 721 SE-lncRNAs were overexpressed, while 247 SE-lncRNAs were underexpressed by 1.5-fold or greater in leiomyoma. Thirteen novel SE-lncRNAs and their corresponding protein coding genes were selected, and their expression was confirmed in eighty-one paired leiomyoma tissues by quantitative real-time PCR. The thirteen pairs of SE-lncRNAs and their corresponding protein coding genes included RP11-353N14.2/CBX4, SOCS2-AS1/SOCS2, RP1-170O19.14/HOXA11, CASC15/PRL, EGFLAM-AS1/EGFLAM, RP11-225H22/NEURL1, RP5-1086K13.1/CD58, AC092839.3/SPTBN1, RP11-69I8.3/CTGF, TM4SF1-AS1/TM4SF1, RP11-373D23/FOSL2, RP11-399K21.11/COMTD1, and CTB-113P19.1/SPARC. Among these SE-lncRNAs, the expression of SOCS2-AS1/SOCS2, RP11-353N14.2/CBX4, RP1-170O19.14/HOXA11, and RP11-225H22/NEURL1 was significantly higher in African Americans as compared with Caucasians. The expression of RP11-353N14.2/CBX4, SOCS2-AS1/SOCS2, CASC15/PRL, and CTB-113P19.1/SPARC was significantly higher in tumors with MED12-mutation-positive as compared with MED12-mutation-negative tumors. Collectively, our results indicate that the differential expression of SE in leiomyomas is another mechanism contributing to dysregulation of protein coding genes in leiomyomas and that race and MED12 mutation can influence the expression of a select group of SE.

Citing Articles

Differential Expression of Small Non-Coding RNAs in Uterine Leiomyomas.

Chuang T, Ton N, Rysling S, Baghdasarian D, Khorram O Int J Mol Sci. 2025; 26(4).

PMID: 40004152 PMC: 11854932. DOI: 10.3390/ijms26041688.

The Functional Role of the Long Non-Coding RNA LINCMD1 in Leiomyoma Pathogenesis.

Chuang T, Ton N, Rysling S, Khorram O Int J Mol Sci. 2024; 25(21).

PMID: 39519092 PMC: 11545963. DOI: 10.3390/ijms252111539.

In Vivo Effects of Bay 11-7082 on Fibroid Growth and Gene Expression: A Preclinical Study.

Chuang T, Ton N, Rysling S, Khorram O Cells. 2024; 13(13.

PMID: 38994944 PMC: 11240737. DOI: 10.3390/cells13131091.

Characterization of m6A Modifiers and RNA Modifications in Uterine Fibroids.

George J, Cancino R, Griffin Miller J, Qiu F, Lin Q, Rowley M Endocrinology. 2024; 165(8).

PMID: 38946397 PMC: 11222979. DOI: 10.1210/endocr/bqae074.

Targeting the long non-coding RNA MIAT for the treatment of fibroids in an animal model.

Chuang T, Ton N, Manrique N, Rysling S, Khorram O Clin Sci (Lond). 2024; 138(12):699-709.

PMID: 38817011 PMC: 11166562. DOI: 10.1042/CS20240190.

References

Chuang T, Luo X, Panda H, Chegini N . miR-93/106b and their host gene, MCM7, are differentially expressed in leiomyomas and functionally target F3 and IL-8. Mol Endocrinol. 2012; 26(6):1028-42. PMC: 3355544. DOI: 10.1210/me.2012-1075. View

Simon J, Kingston R . Occupying chromatin: Polycomb mechanisms for getting to genomic targets, stopping transcriptional traffic, and staying put. Mol Cell. 2013; 49(5):808-24. PMC: 3628831. DOI: 10.1016/j.molcel.2013.02.013. View

Mehine M, Kaasinen E, Heinonen H, Makinen N, Kampjarvi K, Sarvilinna N . Integrated data analysis reveals uterine leiomyoma subtypes with distinct driver pathways and biomarkers. Proc Natl Acad Sci U S A. 2016; 113(5):1315-20. PMC: 4747776. DOI: 10.1073/pnas.1518752113. View

Kopp F, Mendell J . Functional Classification and Experimental Dissection of Long Noncoding RNAs. Cell. 2018; 172(3):393-407. PMC: 5978744. DOI: 10.1016/j.cell.2018.01.011. View

DiMauro A, Seger C, Minor B, Amitrano A, Okeke I, Taya M . Prolactin is Expressed in Uterine Leiomyomas and Promotes Signaling and Fibrosis in Myometrial Cells. Reprod Sci. 2021; 29(9):2525-2535. DOI: 10.1007/s43032-021-00741-w. View

Li S, Fang X, Wang X, Fei B . Fos-like antigen 2 (FOSL2) promotes metastasis in colon cancer. Exp Cell Res. 2018; 373(1-2):57-61. DOI: 10.1016/j.yexcr.2018.08.016. View

Li B, Zhou J, Liu P, Hu J, Jin H, Shimono Y . Polycomb protein Cbx4 promotes SUMO modification of de novo DNA methyltransferase Dnmt3a. Biochem J. 2007; 405(2):369-78. PMC: 1904525. DOI: 10.1042/BJ20061873. View

Luo X, Pan Q, Liu L, Chegini N . Genomic and proteomic profiling II: comparative assessment of gene expression profiles in leiomyomas, keloids, and surgically-induced scars. Reprod Biol Endocrinol. 2007; 5:35. PMC: 2039739. DOI: 10.1186/1477-7827-5-35. View

Misawa A, Takayama K, Urano T, Inoue S . Androgen-induced Long Noncoding RNA (lncRNA) SOCS2-AS1 Promotes Cell Growth and Inhibits Apoptosis in Prostate Cancer Cells. J Biol Chem. 2016; 291(34):17861-80. PMC: 5016176. DOI: 10.1074/jbc.M116.718536. View

10.

Hangauer M, Vaughn I, McManus M . Pervasive transcription of the human genome produces thousands of previously unidentified long intergenic noncoding RNAs. PLoS Genet. 2013; 9(6):e1003569. PMC: 3688513. DOI: 10.1371/journal.pgen.1003569. View

11.

Commandeur A, Styer A, Teixeira J . Epidemiological and genetic clues for molecular mechanisms involved in uterine leiomyoma development and growth. Hum Reprod Update. 2015; 21(5):593-615. PMC: 4533663. DOI: 10.1093/humupd/dmv030. View

12.

Metcalf D, Greenhalgh C, Viney E, Willson T, Starr R, Nicola N . Gigantism in mice lacking suppressor of cytokine signalling-2. Nature. 2000; 405(6790):1069-73. DOI: 10.1038/35016611. View

13.

Wang T, Zhang X, Obijuru L, Laser J, Aris V, Lee P . A micro-RNA signature associated with race, tumor size, and target gene activity in human uterine leiomyomas. Genes Chromosomes Cancer. 2007; 46(4):336-47. DOI: 10.1002/gcc.20415. View

14.

Chuang T, Panda H, Luo X, Chegini N . miR-200c is aberrantly expressed in leiomyomas in an ethnic-dependent manner and targets ZEBs, VEGFA, TIMP2, and FBLN5. Endocr Relat Cancer. 2012; 19(4):541-56. PMC: 3402184. DOI: 10.1530/ERC-12-0007. View

15.

Chen J, Zhang J, Hong L, Zhou Y . EGFLAM correlates with cell proliferation, migration, invasion and poor prognosis in glioblastoma. Cancer Biomark. 2019; 24(3):343-350. PMC: 6484271. DOI: 10.3233/CBM-181740. View

16.

Ulitsky I, Bartel D . lincRNAs: genomics, evolution, and mechanisms. Cell. 2013; 154(1):26-46. PMC: 3924787. DOI: 10.1016/j.cell.2013.06.020. View

17.

Ren W, Zhang J, Li W, Li Z, Hu S, Suo J . A Tumor-Specific Prognostic Long Non-Coding RNA Signature in Gastric Cancer. Med Sci Monit. 2016; 22:3647-3657. PMC: 5072383. DOI: 10.12659/msm.901190. View

18.

Chuang T, Khorram O . Cross-talk between miR-29c and transforming growth factor-β3 is mediated by an epigenetic mechanism in leiomyoma. Fertil Steril. 2019; 112(6):1180-1189. PMC: 6924575. DOI: 10.1016/j.fertnstert.2019.07.1324. View

19.

Guo H, Zhang X, Dong R, Liu X, Li Y, Lu S . Integrated analysis of long noncoding RNAs and mRNAs reveals their potential roles in the pathogenesis of uterine leiomyomas. Oncotarget. 2014; 5(18):8625-36. PMC: 4226709. DOI: 10.18632/oncotarget.2349. View

20.

Jiang X, Gillen S, Esposito I, Giese N, Michalski C, Friess H . Reduced expression of the membrane skeleton protein beta1-spectrin (SPTBN1) is associated with worsened prognosis in pancreatic cancer. Histol Histopathol. 2010; 25(12):1497-506. DOI: 10.14670/HH-25.1497. View